Rasio utang jangka cendhak marang ekuitas: Synaptogenix, Inc. (SNPX)

Logo grafis Synaptogenix (SNPX)

Synaptogenix, Inc. (SNPX) possesses the potential for full pricing power thanks to bryostatin-1, which restores neural connections in dementia. The price trend with the 0.00 indicator complements data regarding collaborations with clinics for testing cognitive drugs. The business currently relies on a single molecule, remaining in the preparation stage for new trial phases following a structural reorganization.

Rasio tanggungan utang jangka cendhak marang modal: Neurotrope (SNPX) kanggo 04.07.2022 - 02.05.2026
Produk mawa merek Synaptogenix Inc.

For the small scientific team at Synaptogenix, Inc. (SNPX), the change in the ratio of short loans to equity on the GURU.Markets platform serves as an indicator of financial stability, where the daily division of short-term liabilities by equity allows for the tracking of share dilution risks and an assessment of the effectiveness of resource austerity measures amid limited market confidence in early-stage neuro-drugs.

Karo sapa Synaptogenix, Inc. saingan

Utang jangka cendhak marang modal BIIB|NBIX - Kewajiban jangka cendhak marang modal|Regencell Bioscience - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal axsome.com AXSM|ACAD - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Supernus Corp (SUPN)|Utang jangka cendhak marang ekuitas Catalyst Pharmaceuticals|denalitherapeutics.com (DNLI) - Koefisien utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas HRMY (Harmony Biosciences Holdings, Inc.)|BHVN - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Amylyx AMLX|TRVI: Rasio utang jangka cendhak marang modal|Praxis Precision Medicines - Utang jangka cendhak marang modal|AVXL - Utang jangka cendhak marang modal|CeriBell (CBLL) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang ekuitas PRTA (Prothena Biosciences)|Rasio utang jangka cendhak marang ekuitas ALEC|ANNX (Annexon Biosciences Inc.) - Rasio silihan jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Omeros Corporation (OMER)|NGNE - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang modal ACIU (AC Immune SA)|Tanggungan utang jangka cendhak marang ekuitas Voyager Therapeutics Inc|Neumora Therapeutics Inc - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Scilex Holding Company, Inc.|Tevogen Bio Holdings (TVGN) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal ACOG|CGTX (Cognition Therapeutics, Inc.) - Utang jangka cendhak marang modal|Inhibikase Therapeutics Inc (IKT) - Koefisien utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas SAVA (Cassava)|assertiotx.com - Rasio utang jangka cendhak marang modal|Coya Therapeutics - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal VTGN|Ovid Rx - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal Acumen Pharmaceuticals Inc. ABOS|CervoMed Inc (CRVO) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal ATHE|CLNN (Clene Inc) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas PepGen Corp (PEPG)|Rasio utang jangka cendhak marang ekuitas JUNS (Jupiter Neurosciences)|Koefisien utang jangka cendhak marang modal Relmada Therapeutics Inc|Utang jangka cendhak marang ekuitas Annovis Bio Corp ANVS|Koefisien utang jangka cendhak marang modal Grace Therapeutics Inc (GRCE)|AIFF - Utang jangka cendhak marang ekuitas|KLTO (Klotho Neurosciences Inc) - Rasio utang jangka cendhak marang modal|neurosense-tx.com (NRSN) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang ekuitas RVPH (Reviva Pharmaceuticals Holdings Inc.)|Rasio utang jangka cendhak marang ekuitas MTVA|Rasio utang jangka cendhak marang modal NRXS (NeurAxis Inc)|Utang jangka cendhak marang ekuitas Helius Medical (HSDT)|passagebio.com - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang modal NEUP (Neuphoria Therapeutics)|Minerva Neurosciences Inc (NERV) - Kewajiban jangka cendhak marang modal|ATHA: Rasio utang jangka cendhak marang ekuitas|ADXN - Utang jangka cendhak marang modal|alzamend.com (ALZN) - Utang jangka cendhak marang ekuitas|Cyclerion Therapeutics, Inc. - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Protagenic Therapeutics Inc.|Kewajiban jangka cendhak marang modal Pasithea KTTA|Utang jangka cendhak marang ekuitas Cortigent, Inc. (CRGT)|Koefisien utang jangka cendhak marang modal Avenue Therapeutics Inc|Brainstorm Cell - Rasio utang jangka cendhak marang ekuitas|caratherapeutics.com (CARA) - Kewajiban jangka cendhak marang modal|CHRO - Utang jangka cendhak marang ekuitas|ELYM (Eliem Therapeutics) - Rasio utang jangka cendhak marang modal|ITCI: Utang jangka cendhak marang modal|Longboard (LBPH) - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Marinus Pharmaceuticals|nkgenbiotech.com - Kewajiban jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas NRBO (NeuroBo Pharmaceuticals, Inc.)|Rasio silihan jangka cendhak marang modal SAGE|Utang jangka cendhak marang ekuitas Trevena, Inc TRVN|Vigil Neuroscience Inc. (VIGL) - Kewajiban jangka cendhak marang modal|Anew Medical, Inc. - Utang jangka cendhak marang modal|Tanggungan utang jangka cendhak marang ekuitas cerevel.com (CERE)